发明名称 |
AN EDIBLE COMPOSITION COMPRISING RESVERATROL AND FLAVONOID MONOGLUCOSIDE |
摘要 |
Foods or meals high in available carbohydrate such as sucrose or starch increase postprandial blood glucose concentrations. Repeated high post-prandial plasma glucose “spikes” are associated with an increased risk of developing type II diabetes. Unregulated glycemic excursions are undesirable, and any reduction or “blunting” of the post-prandial glucose concentration in blood is potentially beneficial. This invention relates to an edible composition for delay of intestinal glucose uptake through synergistic inhibition of both active sodium glucose co-transporter 1 (SGLT1) and passive glucose transporter 2 (GLUT2) leading to flattening or blunting of the post-prandial glucose peak. In a first aspect of the invention, an edible composition is provided, in the form of a single serving of one or more unit dosages, wherein the edible composition comprises 20-2000, preferably 30-1000, most preferably 40-500 mg a 3,5-dihydroxy-trans-stilbene and 10-2000, preferably 20-1000, most preferably 40-500 mg flavonoid mono-glucoside or dihydrochalcone monoglucoside. |
申请公布号 |
US2015313927(A1) |
申请公布日期 |
2015.11.05 |
申请号 |
US201314647751 |
申请日期 |
2013.11.27 |
申请人 |
Berry Mark John;Fowler Mark Ian;Heath Alan David |
发明人 |
Berry Mark John;Fowler Mark Ian;Heath Alan David |
分类号 |
A61K31/7048;A23L1/30;A23L2/52;A61K31/05 |
主分类号 |
A61K31/7048 |
代理机构 |
|
代理人 |
|
主权项 |
1. An edible composition, in the form of a single serving of one or more unit dosages, wherein the edible composition comprises 20-2000, preferably 30-1000, most preferably 40-500 mg a 3,5-dihydroxy-trans-stilbene and 10-2000, preferably 20-1000, most preferably 40-500 mg flavonoid monoglucoside or dihydrochalcone monoglucoside. |
地址 |
Bedfordshire GB |